239 related articles for article (PubMed ID: 12833455)
1. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience.
Daneshmand S; Quek ML; Huffman JL
Cancer; 2003 Jul; 98(1):55-60. PubMed ID: 12833455
[TBL] [Abstract][Full Text] [Related]
2. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Chen GL; Bagley DH
J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
[TBL] [Abstract][Full Text] [Related]
3. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
[TBL] [Abstract][Full Text] [Related]
4. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
Boorjian S; Ng C; Munver R; Palese MA; Vaughan ED; Sosa RE; Del Pizzo JJ; Scherr DS
Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
[TBL] [Abstract][Full Text] [Related]
5. Retrograde endoscopic laser therapy and ureteroscopic surveillance for transitional cell carcinoma of the upper urinary tract.
Mugiya S; Ozono S; Nagata M; Otsuka A; Takayama T; Nagae H
Int J Urol; 2006 Jan; 13(1):1-6. PubMed ID: 16448423
[TBL] [Abstract][Full Text] [Related]
6. Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome.
Reisiger K; Hruby G; Clayman RV; Landman J
Urology; 2007 Aug; 70(2):263-6. PubMed ID: 17826486
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
[TBL] [Abstract][Full Text] [Related]
8. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
9. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
10. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma.
Elliott DS; Blute ML; Patterson DE; Bergstralh EJ; Segura JW
Urology; 1996 Jun; 47(6):819-25. PubMed ID: 8677570
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
[TBL] [Abstract][Full Text] [Related]
13. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.
Keeley FX; Bibbo M; Bagley DH
J Urol; 1997 May; 157(5):1560-5. PubMed ID: 9112476
[TBL] [Abstract][Full Text] [Related]
14. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection.
Rouprêt M; Traxer O; Tligui M; Conort P; Chartier-Kastler E; Richard F; Cussenot O
Eur Urol; 2007 Mar; 51(3):709-13; discussion 714. PubMed ID: 16911852
[TBL] [Abstract][Full Text] [Related]
15. Imperative indications for conservative management of upper tract transitional cell carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
Goel MC; Mahendra V; Roberts JG
J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy.
Taweemonkongsap T; Nualyong C; Amornvesukit T; Leewansangtong S; Srinualnad S; Chaiyaprasithi B; Sujijantararat P; Tantiwong A; Soontrapa S
World J Surg Oncol; 2008 Jan; 6():3. PubMed ID: 18194580
[TBL] [Abstract][Full Text] [Related]
18. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
[TBL] [Abstract][Full Text] [Related]
19. 13-year experience with percutaneous management of upper tract transitional cell carcinoma.
Clark PE; Streem SB; Geisinger MA
J Urol; 1999 Mar; 161(3):772-5; discussion 775-6. PubMed ID: 10022682
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic management of upper tract urothelial tumors.
Stoller ML; Gentle DL; McDonald MW; Reese JH; Tacker JR; Carroll PR; Best C
Tech Urol; 1997; 3(3):152-7. PubMed ID: 9422447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
